Heilig CW, Saunders T, Brosius FC 3rd, Moley K, Heilig K, Baggs R, Guo L, Conner D (2003) Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy
Current interventions focus on surgical decompression, reduction of secondary pathology, and steroid use to suppress inflammation and edema (240)
On the record
In 2014, the FDA granted AOD 9604 Human GRAS (Generally Recognized As Safe) status, indicating a favorable safety profile when used as directed
Not for human consumption or therapeutic use
If the condition causes emotional distress or affects a persons social interactions, treatment can help alleviate these psychological aspects